This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chabot, D. J.
Right arrow Articles by Broder, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chabot, D. J.
Right arrow Articles by Broder, C. C.

 Previous Article  |  Next Article 

Journal of Virology, August 1999, p. 6598-6609, Vol. 73, No. 8
0022-538X/99/$04.00+0

Mutagenesis of CXCR4 Identifies Important Domains for Human Immunodeficiency Virus Type 1 X4 Isolate Envelope-Mediated Membrane Fusion and Virus Entry and Reveals Cryptic Coreceptor Activity for R5 Isolates

Donald J. Chabot,1 Peng-Fei Zhang,2 Gerald V. Quinnan,2 and Christopher C. Broder1,*

Departments of Microbiology and Immunology1 and Preventive Medicine and Biometrics,2 Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814-4799

Received 31 December 1998/Accepted 27 April 1999

CXCR4 is a chemokine receptor and a coreceptor for T-cell-line-tropic (X4) and dual-tropic (R5X4) human immunodeficiency virus type 1 (HIV-1) isolates. Cells coexpressing CXCR4 and CD4 will fuse with appropriate HIV-1 envelope glycoprotein (Env)-expressing cells. The delineation of the critical regions involved in the interactions within the Env-CD4-coreceptor complex are presently under intensive investigation, and the use of chimeras of coreceptor molecules has provided valuable information. To define these regions in greater detail, we have employed a strategy involving alanine-scanning mutagenesis of the extracellular domains of CXCR4 coupled with a highly sensitive reporter gene assay for HIV-1 Env-mediated membrane fusion. Using a panel of 41 different CXCR4 mutants, we have identified several charged residues that appear important for coreceptor activity for X4 Envs; the mutations E15A (in which the glutamic acid residue at position 15 is replaced by alanine) and E32A in the N terminus, D97A in extracellular loop 1 (ecl-1), and R188A in ecl-2 impaired coreceptor activity for X4 and R5X4 Envs. In addition, substitution of alanine for any of the four extracellular cysteines alone resulted in conformational changes of various degrees, while mutants with paired cysteine deletions partially retained their structure. Our data support the notion that all four cysteines are involved in disulfide bond formation. We have also identified substitutions which greatly enhance or convert CXCR4's coreceptor activity to support R5 Env-mediated fusion (N11A, R30A, D187A, and D193A), and together our data suggest the presence of conserved extracellular elements, common to both CXCR4 and CCR5, involved in their coreceptor activities. These data will help us to better detail the CXCR4 structural requirements exhibited by different HIV-1 strains and will direct further mutagenesis efforts aimed at better defining the domains in CXCR4 involved in the HIV-1 Env-mediated fusion process.

* Corresponding author. Mailing address: Department of Microbiology and Immunology, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd., Bethesda, MD 20814-4799. Phone: (301) 295-3401. Fax: (301) 295-1545. E-mail: cbroder{at}mxb.usuhs.mil.

Journal of Virology, August 1999, p. 6598-6609, Vol. 73, No. 8
0022-538X/99/$04.00+0


This article has been cited by other articles:

  • Thakkar, N., Pirrone, V., Passic, S., Zhu, W., Kholodovych, V., Welsh, W., Rando, R. F., Labib, M. E., Wigdahl, B., Krebs, F. C. (2009). Specific Interactions between the Viral Coreceptor CXCR4 and the Biguanide-Based Compound NB325 Mediate Inhibition of Human Immunodeficiency Virus Type 1 Infection. Antimicrob. Agents Chemother. 53: 631-638 [Abstract] [Full Text]  
  • Kapur, A., Samaniego, P., Thakur, G. A., Makriyannis, A., Abood, M. E. (2008). Mapping the Structural Requirements in the CB1 Cannabinoid Receptor Transmembrane Helix II for Signal Transduction. J. Pharmacol. Exp. Ther. 325: 341-348 [Abstract] [Full Text]  
  • Nolan, K. M., Jordan, A. P. O., Hoxie, J. A. (2008). Effects of Partial Deletions within the Human Immunodeficiency Virus Type 1 V3 Loop on Coreceptor Tropism and Sensitivity to Entry Inhibitors. J. Virol. 82: 664-673 [Abstract] [Full Text]  
  • Kubo, Y., Yokoyama, M., Yoshii, H., Mitani, C., Tominaga, C., Tanaka, Y., Sato, H., Yamamoto, N. (2007). Inhibitory role of CXCR4 glycan in CD4-independent X4-tropic human immunodeficiency virus type 1 infection and its abrogation in CD4-dependent infection. J. Gen. Virol. 88: 3139-3144 [Abstract] [Full Text]  
  • Xu, C., Sui, J., Tao, H., Zhu, Q., Marasco, W. A. (2007). Human Anti-CXCR4 Antibodies Undergo VH Replacement, Exhibit Functional V-Region Sulfation, and Define CXCR4 Antigenic Heterogeneity. J. Immunol. 179: 2408-2418 [Abstract] [Full Text]  
  • Choi, W.-T., Tian, S., Dong, C.-Z., Kumar, S., Liu, D., Madani, N., An, J., Sodroski, J. G., Huang, Z. (2005). Unique Ligand Binding Sites on CXCR4 Probed by a Chemical Biology Approach: Implications for the Design of Selective Human Immunodeficiency Virus Type 1 Inhibitors. J. Virol. 79: 15398-15404 [Abstract] [Full Text]  
  • Zaitseva, M., Romantseva, T., Manischewitz, J., Wang, J., Goucher, D., Golding, H. (2005). Increased CXCR4-dependent HIV-1 fusion in activated T cells: role of CD4/CXCR4 association. J. Leukoc. Biol. 78: 1306-1317 [Abstract] [Full Text]  
  • Tian, S., Choi, W.-T., Liu, D., Pesavento, J., Wang, Y., An, J., Sodroski, J. G., Huang, Z. (2005). Distinct Functional Sites for Human Immunodeficiency Virus Type 1 and Stromal Cell-Derived Factor 1{alpha} on CXCR4 Transmembrane Helical Domains. J. Virol. 79: 12667-12673 [Abstract] [Full Text]  
  • Carnec, X., Quan, L., Olson, W. C., Hazan, U., Dragic, T. (2005). Anti-CXCR4 Monoclonal Antibodies Recognizing Overlapping Epitopes Differ Significantly in Their Ability To Inhibit Entry of Human Immunodeficiency Virus Type 1. J. Virol. 79: 1930-1933 [Abstract] [Full Text]  
  • Yi, Y., Singh, A., Shaheen, F., Louden, A., Lee, C., Collman, R. G. (2003). Contrasting Use of CCR5 Structural Determinants by R5 and R5X4 Variants within a Human Immunodeficiency Virus Type 1 Primary Isolate Quasispecies. J. Virol. 77: 12057-12066 [Abstract] [Full Text]  
  • Lin, G., Baribaud, F., Romano, J., Doms, R. W., Hoxie, J. A. (2002). Identification of gp120 Binding Sites on CXCR4 by Using CD4-Independent Human Immunodeficiency Virus Type 2 Env Proteins. J. Virol. 77: 931-942 [Abstract] [Full Text]  
  • Lapham, C. K., Romantseva, T., Petricoin, E., King, L. R., Manischewitz, J., Zaitseva, M. B., Golding, H. (2002). CXCR4 heterogeneity in primary cells: possible role of ubiquitination. J. Leukoc. Biol. 72: 1206-1214 [Abstract] [Full Text]  
  • Basmaciogullari, S., Babcock, G. J., Van Ryk, D., Wojtowicz, W., Sodroski, J. (2002). Identification of Conserved and Variable Structures in the Human Immunodeficiency Virus gp120 Glycoprotein of Importance for CXCR4 Binding. J. Virol. 76: 10791-10800 [Abstract] [Full Text]  
  • Zhou, N., Luo, Z., Luo, J., Fan, X., Cayabyab, M., Hiraoka, M., Liu, D., Han, X., Pesavento, J., Dong, C.-Z., Wang, Y., An, J., Kaji, H., Sodroski, J. G., Huang, Z. (2002). Exploring the Stereochemistry of CXCR4-Peptide Recognition and Inhibiting HIV-1 Entry with D-Peptides Derived from Chemokines. J. Biol. Chem. 277: 17476-17485 [Abstract] [Full Text]  
  • Hoffman, N. G., Seillier-Moiseiwitsch, F., Ahn, J., Walker, J. M., Swanstrom, R. (2002). Variability in the Human Immunodeficiency Virus Type 1 gp120 Env Protein Linked to Phenotype-Associated Changes in the V3 Loop. J. Virol. 76: 3852-3864 [Abstract] [Full Text]  
  • Thompson, D. A. D., Cormier, E. G., Dragic, T. (2002). CCR5 and CXCR4 Usage by Non-Clade B Human Immunodeficiency Virus Type 1 Primary Isolates. J. Virol. 76: 3059-3064 [Abstract] [Full Text]  
  • Pontow, S., Ratner, L. (2001). Evidence for Common Structural Determinants of Human Immunodeficiency Virus Type 1 Coreceptor Activity Provided through Functional Analysis of CCR5/CXCR4 Chimeric Coreceptors. J. Virol. 75: 11503-11514 [Abstract] [Full Text]  
  • Tanaka, R., Yoshida, A., Murakami, T., Baba, E., Lichtenfeld, J., Omori, T., Kimura, T., Tsurutani, N., Fujii, N., Wang, Z.-X., Peiper, S. C., Yamamoto, N., Tanaka, Y. (2001). Unique Monoclonal Antibody Recognizing the Third Extracellular Loop of CXCR4 Induces Lymphocyte Agglutination and Enhances Human Immunodeficiency Virus Type 1-Mediated Syncytium Formation and Productive Infection. J. Virol. 75: 11534-11543 [Abstract] [Full Text]  
  • Zhou, N., Luo, Z., Luo, J., Liu, D., Hall, J. W., Pomerantz, R. J., Huang, Z. (2001). Structural and Functional Characterization of Human CXCR4 as a Chemokine Receptor and HIV-1 Co-receptor by Mutagenesis and Molecular Modeling Studies. J. Biol. Chem. 276: 42826-42833 [Abstract] [Full Text]  
  • Dragic, T. (2001). An overview of the determinants of CCR5 and CXCR4 co-receptor function. J. Gen. Virol. 82: 1807-1814 [Full Text]  
  • Labrosse, B., Treboute, C., Brelot, A., Alizon, M. (2001). Cooperation of the V1/V2 and V3 Domains of Human Immunodeficiency Virus Type 1 gp120 for Interaction with the CXCR4 Receptor. J. Virol. 75: 5457-5464 [Abstract] [Full Text]  
  • Van Drenth, C., Jenkins, A., Ledwich, L., Ryan, T. C., Mashikian, M. V., Brazer, W., Center, D. M., Cruikshank, W. W. (2000). Desensitization of CXC Chemokine Receptor 4, Mediated by IL-16/CD4, Is Independent of p56lck Enzymatic Activity. J. Immunol. 165: 6356-6363 [Abstract] [Full Text]  
  • Hug, P., Lin, H.-M. J., Korte, T., Xiao, X., Dimitrov, D. S., Wang, J. M., Puri, A., Blumenthal, R. (2000). Glycosphingolipids Promote Entry of a Broad Range of Human Immunodeficiency Virus Type 1 Isolates into Cell Lines Expressing CD4, CXCR4, and/or CCR5. J. Virol. 74: 6377-6385 [Abstract] [Full Text]  
  • Chabot, D. J., Chen, H., Dimitrov, D. S., Broder, C. C. (2000). N-Linked Glycosylation of CXCR4 Masks Coreceptor Function for CCR5-Dependent Human Immunodeficiency Virus Type 1 Isolates. J. Virol. 74: 4404-4413 [Abstract] [Full Text]  
  • Brelot, A., Heveker, N., Montes, M., Alizon, M. (2000). Identification of Residues of CXCR4 Critical for Human Immunodeficiency Virus Coreceptor and Chemokine Receptor Activities. J. Biol. Chem. 275: 23736-23744 [Abstract] [Full Text]  
  • Chabot, D. J., Broder, C. C. (2000). Substitutions in a Homologous Region of Extracellular Loop 2 of CXCR4 and CCR5 Alter Coreceptor Activities for HIV-1 Membrane Fusion and Virus Entry. J. Biol. Chem. 275: 23774-23782 [Abstract] [Full Text]  
  • Valenzuela-Fernandez, A., Palanche, T., Amara, A., Magerus, A., Altmeyer, R., Delaunay, T., Virelizier, J.-L., Baleux, F., Galzi, J.-L., Arenzana-Seisdedos, F. (2001). Optimal Inhibition of X4 HIV Isolates by the CXC Chemokine Stromal Cell-derived Factor 1alpha Requires Interaction with Cell Surface Heparan Sulfate Proteoglycans. J. Biol. Chem. 276: 26550-26558 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»